Yemaachi Biotech

Developing new anti-cancer drugs that are effective in diverse populations | YC S21

Biotechnology Research
Accra
11-50 employees

About Yemaachi Biotech

Yemaachi is a biotechnology company dedicated to improving health outcomes by diversifying genomic data, with a focus on African populations. It develops and sells diagnostic test kits and offers advanced genomic testing services directly to consumers and healthcare providers. The company also engages in strategic partnerships with global pharmaceutical firms for large-scale research in areas like cancer genomics and vaccine development.

Company Classification

Customer Types
B2CB2B
Business Models
ProductsServices
Product & Service Types
Diagnostic test kitsGenomic research servicesClinical and at-home diagnostic testing

Customers

CustomerSuccess StorySource
Roche
Yemaachi launched the African Cancer Atlas in partnership with Roche
BioNTech
Yemaachi Biotechnology partnered with BioNTech to advance a novel mRNA-based malaria vaccine project and to accelerate the development of an oncology center of excellence in Africa, combining BioNTech’s expertise in mRNA vaccine development with Yemaachi’s deep understanding of the local landscape and clinical research.
Nice Try
Sign up to Ethos to access the full customer list
Sign up to Ethos
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.Source

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos